Advertisement

Classification and Spectrum

  • Gregory J. Dore
  • David A. Cooper

Keywords

Human Immunodeficiency Virus Human Immunodeficiency Virus Infection Herpes Zoster Pneumocystis Carinii Pneumonia Human Immunodeficiency Virus Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Centers for Disease Control and Prevention: Update on acquired immunodeficiency syndrome (AIDS)—United States. MMWR 1982, 31:507–508, 513–514.Google Scholar
  2. 2.
    Centers for Disease Control and Prevention: Revision of the case definition of acquired immunodeficiency syndrome for national reporting—United States. MMWR 1985, 34:373–375.Google Scholar
  3. 3.
    Centers for Disease Control and Prevention: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987, 36(suppl 1S):3S–15S.Google Scholar
  4. 4.
    Centers for Disease Control and Prevention: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS. MMWR 1992, 41[RR-17]:1–19.Google Scholar
  5. 5.
    Pedersen C, Lindhart BO, Jensen BL, et al.: Clinical course of primary HIV infection: Consequences for subsequent course of infection. BMJ 1989, 299:154–157.PubMedCrossRefGoogle Scholar
  6. 6.
    Tindall B, Barker S, Donovan B, et al.: Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med 1988, 148:945–949.PubMedCrossRefGoogle Scholar
  7. 7.
    Gaines H, von Sydow, Pehrson PO, et al.: Clinical picture of primary HIV infection presenting as a glandular-fever-like illness. Br Med J 1988, 297:1363–1368.CrossRefGoogle Scholar
  8. 8.
    Hulsebosch HJ, Ciaessen FAP, van Ginkel CJW, et al.: Human immunodeficiency virus exanthem. J Am Acad Dermatol 1990, 23:483–486.PubMedCrossRefGoogle Scholar
  9. 9.
    Rabeneck L, Popovic M, Gartner S, et al.: Acute co-infection with human immunodeficiency virus (HIV) and esophageal ulcers. JAMA 1990, 263:2318–2332.PubMedCrossRefGoogle Scholar
  10. 10.
    Kaufmann GR, Cunningham P, Zaunders J, et al.: Impact of early HIV-1 RNA and T-lymphocyte dynamics during primary HIV-1 infection on the subsequent course of HIV-1 RNA levels and CD4+ T-lymphocyte counts in the first year of HIV-1 infection. J Acquir Defic Syndr 1999, 22:437–444.Google Scholar
  11. 11.
    Albert J, Gaines H, Sonnerborg A, et al.: Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection. J Med Virol 1987, 23:67–73.PubMedCrossRefGoogle Scholar
  12. 12.
    von Sydow M, Gaines H, Sonnerborg A, et al.: Antigen detection in primary HIV infection. BMJ 1988, 296:238–240.CrossRefGoogle Scholar
  13. 13.
    Cooper DA, Imrie AA, Penny R: Antibody response to human immunodeficiency virus following primary infection. J Infect Dis 1987, 115:1113–1118.CrossRefGoogle Scholar
  14. 14.
    Centers for Disease Control and Prevention: Classification system for human T-Iymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 1986, 35:334–339.Google Scholar
  15. 15.
    Cilla G, Trallero EP, Furundarena JR, et al.: Esophageal candidiasis and immunodeficiency associated with acute HIV infection. AIDS 1988, 2:399–400.PubMedCrossRefGoogle Scholar
  16. 16.
    Tindall B, Hing M, Edwards P, et al.: Severe clinical manifestations of primary HIV infection. AIDS 1989, 3:747–749.PubMedCrossRefGoogle Scholar
  17. 17.
    Vento S, DiPerri G, Garofano T, et al.: Pneumocystis carinii pneumonia during primary HIV-1 infection. Lancet 1993, 324:24–25.CrossRefGoogle Scholar
  18. 18.
    Kotler DP: Gastrointestinal and Nutritional Manifestations of AIDS. New York: Raven Press; 1991.Google Scholar
  19. 19.
    Kotler DP, Tierney AR, Culpepper-Morgan JA, et al.: Effect of home total parenteral nutrition upon body composition in patients with AIDS. JPEN 1990, 14:454–458.CrossRefGoogle Scholar
  20. 20.
    Centers for Disease Control and Prevention: Persistent, generalized lymphadenopathy among homosexual males. MMWR 1982, 31:249–250.Google Scholar
  21. 21.
    Farthing CF, Brown SE, Staughton RCD: A Colour Atlas of AIDS and HIV Disease. 2nd ed. London: Wolfe Medical Publications, Ltd: 1988:29.Google Scholar
  22. 22.
    Gherardi R, Belec L, Mhiric C, et al.: The spectrum of vasculitis in human immunodeficiency virus-infected patients. Arthritis Rheum 1993, 36:1164–1174.PubMedCrossRefGoogle Scholar
  23. 23.
    Berman A, Espinoza LR, Diaz JD, et al.: Rheumatic manifestations of human immunodeficiency virus infection. Am J Med 1988, 85:59–64.PubMedCrossRefGoogle Scholar
  24. 24.
    Seifert M: The Rheumatology of HIV Infection (Topical Reviews, no. 11). Arthritis and Rheumatism Council for Research, Jan 1989.Google Scholar
  25. 25.
    Davis P, Stein M, Latif S, Emmanuel J: HIV and polyarthritis. Lancet 1988, i:936.CrossRefGoogle Scholar
  26. 26.
    Melbye M, Grossman RJ, Goedert JJ: Risk of AIDS after herpes zoster. Lancet 1987, i:728–730.CrossRefGoogle Scholar
  27. 27.
    Ryder JW, Croen K, Kleinschmidt-de Masters BK, et al.: Progressive encephalitis three months after resolution of cutaneous zoster in a patient with AIDS. Ann Neurol 1986, 19:182–188.PubMedCrossRefGoogle Scholar
  28. 28.
    Dolin R, Reichman RC, Mazur MH, et al.: Herpes zoster and varicella infections in immunosuppressed patients. Ann Intern Med 1978, 89:375–388.PubMedCrossRefGoogle Scholar
  29. 29.
    Narain JP, Raviglione MC, Kochi A: HIV-associated tuberculosis in developing countries: Epidemiology and strategies for prevention. Tuber Lung Dis 1992;73:311–321.PubMedCrossRefGoogle Scholar
  30. 30.
    Couldwell DL, Dore GL, Harkness JL, et al.: Nosocomial outbreak of tuberculosis in an outpatient HIV treatment room. AIDS 1996; 10:521–525.PubMedCrossRefGoogle Scholar
  31. 31.
    Jacobson MA, French M: Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy. AIDS 1998, 12:S157–S163.CrossRefGoogle Scholar
  32. 32.
    Carr A, Samaras K, Burton S, et al.: A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998, 12:F51–F59.CrossRefGoogle Scholar

Selected Bibliography

  1. Albert J, Gaines H, Sonnerborg A, et al.: Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection. J Med Virol 1987, 23:67–73.PubMedCrossRefGoogle Scholar
  2. Carr A, Samaras K, Burton S, et al.: A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998, 12:F51–F59.CrossRefGoogle Scholar
  3. Centers for Disease Control and Prevention: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41 [RR-17]: 1–19.Google Scholar
  4. Cooper DA, Gold J, Maclean P, et al.: Acute AIDS retrovirus infection: Definition of a clinical illness associated with seroconversion. Lancet 1985, i:537–540.CrossRefGoogle Scholar
  5. Jacobson MA, French M: Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy. AIDS 1998, 12:S157–S163.CrossRefGoogle Scholar
  6. Tindall B, Barker S, Donovan B, et al.: Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med 1988, 148:945–949.PubMedCrossRefGoogle Scholar
  7. Tindall B, Hing M, Edwards P, et al.: Severe clinical manifestations of primary HIV infection. AIDS 1989, 3:747–749.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Gregory J. Dore
  • David A. Cooper

There are no affiliations available

Personalised recommendations